← Back to headlines
GLP-1 Drugs Like Mounjaro and Ozempic Show Benefits for Diabetes and Weight Loss
New research indicates that the reduction in obesity-related disease risk is directly tied to the amount of weight lost using GLP-1 drugs, such as Ozempic. Additionally, Lilly's Mounjaro has been found to outperform other GLP-1s for some type 2 diabetes patients.
29 May, 11:03 — 29 May, 11:03
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: index-hr · 28 May, 19:58|Full coverage: 2 · 15h|Window: 15h
Left-leaningCenterRight-leaning
Related Stories
Critical Heat Measurements in Vienna Senior Apartments Prompt Calls for Subsidized Air Conditioning
10m ago
New Study Reveals High CTE Prevalence in Deceased NFL Players
21m ago
Latvian Government Increases Funding for Home Hospice Care
21m ago
Europe Records Over 35,000 Excess Deaths Due to Heatwaves
1h ago